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Abstract
Motivation: Late onset Alzheimer’s disease is currently a disease with no known effective treatment
options. To better understand disease, new multi-omic data-sets have recently been generated with
the goal of identifying molecular causes of disease. However, most analytic studies using these
datasets focus on uni-modal analysis of the data. Here, we propose a data driven approach to inte-
grate multiple data types and analytic outcomes to aggregate evidences to support the hypothesis
that a gene is a genetic driver of the disease. The main algorithmic contributions of our article are:
(i) a general machine learning framework to learn the key characteristics of a few known driver
genes from multiple feature sets and identifying other potential driver genes which have similar fea-
ture representations, and (ii) A flexible ranking scheme with the ability to integrate external valid-
ation in the form of Genome Wide Association Study summary statistics. While we currently focus
on demonstrating the effectiveness of the approach using different analytic outcomes from RNA-
Seq studies, this method is easily generalizable to other data modalities and analysis types.
Results: We demonstrate the utility of our machine learning algorithm on two benchmark multi-
view datasets by significantly outperforming the baseline approaches in predicting missing labels.
We then use the algorithm to predict and rank potential drivers of Alzheimer’s. We show that our
ranked genes show a significant enrichment for single nucleotide polymorphisms associated with
Alzheimer’s and are enriched in pathways that have been previously associated with the disease.
Availability and implementation: Source code and link to all feature sets is available at https://
github.com/Sage-Bionetworks/EvidenceAggregatedDriverRanking.
Contact: ben.logsdon@sagebionetworks.org
1 Introduction
Late onset Alzheimer’s disease (LOAD) is a debilitating illness with no
known disease modifying treatment (Alzheimer’s, 2015; Frozza et al.,
2018). To address this, there have been a recent surge in the gener-
ation of multi-modality data (Hodes and Buckholtz, 2016; Mueller
et al., 2005) to understand the biology of the disease and potential
drivers that causally regulate it. Identification new genetic drivers of
LOAD will be key to the development of effective disease modifying
therapeutics. To prioritize experimental evaluation of LOAD drivers,
we present a data driven approach to rank genes based on the prob-
ability that they drive LOAD using transcriptional (RNA-seq) data
collected from postmortem brain tissue in patient cohorts.
While there exists some prior work on driver gene ranking
(Grechkin et al., 2016; Hou and Ma, 2014; Liu et al., 2015;
Mukherjee et al., 2018; Zhang et al., 2013), these approaches have
several limitations that make them unsuitable for all feature types.
Many of these approaches work only with somatic mutation data
from patients tumor samples, ranking genes by comparing the muta-
tion rates of somatic variants in patients for different genes to an ap-
propriate null model to identify cancer driver genes (Tian et al.,
2014). While some other approaches use ensemble approaches to
rank genes using predictions from other tools that use genomic data
(Liu et al., 2015). Unfortunately, these approaches are highly speci-
alized to the type of data and cannot be easily generalized to a
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broader class of feature sets. Furthermore, while in cancer driver
genes are defined based on somatic genetic variation, in complex
diseases such as Alzheimer’s disease we define driver genes as those
that are causally affecting risk of disease via germline genetic vari-
ation. While there exist approaches such as DawnRank (Hou and
Ma, 2014) which utilize RNA-Seq data in addition to genomic data
for each patient, these too have strong modeling assumptions lead-
ing to lack of generalizability. Furthermore, most of these previous
approaches are designed for detecting driver genes that are driven by
somatic mutation events aside from the Key Driver analysis of
Zhang and Zhu (2013). Alternatively, we are interested in identify-
ing signatures of driverness from somatic tissue that are indicative of
germline risk for LOAD. Here, we propose a highly generalizable
machine learning approach to learn signatures of germline genetic
risk within summaries of transcriptomic expression of somatic post-
mortem brain tissue driver ranking and demonstrate it’s effective-
ness on RNA-Seq derived feature sets.
Our driver ranking approach serves as an evidence aggregation
framework, and currently uses differential expression, undirected
gene networks inferred with an ensemble co-expression network in-
ference method and co-expression module summaries (Logsdon
et al., 2019) generated using transcriptional data collected from
postmortem brain tissue across three studies (ROSMAP, Mayo
RNAseq, MSBB) in AMP-AD. We assume that each analytic sum-
mary (while originating from the same RNA-seq data-sets) contains
independently predictive information that can be used to identify
genes with a burden of germline AD risk variants. We process these
independent analytic summaries into the following feature sets (see
Table 1) to be used for machine learning: (i) genes that are differen-
tially expressed between AD cases and controls in specific brain
regions, (ii) global un-directed network topological features for spe-
cific brain regions and (iii) module specific network topological fea-
tures for 42 tissue specific co-expression modules.
Here, we divide the task of ranking potential driver genes into
two sub-tasks: (i) training machine learning models to identify prob-
abilities of genes being driver genes using each feature set, (ii) aggre-
gation of predictions of models for each feature set along with
independent Genome Wide Association Study (GWAS) statistics to
rank potential driver genes (Fig. 1). The primary goal of the first
task is to learn the unique characteristics of 27 previously known
drivers of AD identified from published LOAD GWAS studies
(Kunkle et al., 2019; Lambert et al., 2013) and use it to identify po-
tential novel drivers of the disease. These AD drivers were defined as
loci that were genome-wide significant in one study (P<5  108),
with significant replication P-value (P<0.05) in a second study.
The technical challenges associated with the first task include find-
ing an appropriate approach to identify the driver probabilities and
finding a way to learn from sparsely labeled data (only 27 genes
have labels, while others may or may not be driver genes). To tackle
this, here we propose a novel multiview classification (Xu et al.,
2013) approach, which includes iterative update of labels to infer
additional candidate driver genes. For the latter task the primary
challenge is to define an appropriate scoring system to rank genes.
Here, we propose a flexible scoring system that not only utilizes
model predictions for each feature set but also independent LOAD
GWAS statistics.
We demonstrate our multiview classification algorithm achieves
substantially higher performance compared with models trained for
individual feature sets on standardized multiview datasets. We then
demonstrate that similar performance benefits hold when applied to
LOAD postmortem brain tissue RNA-seq using qualitative metrics.
We observe that global network topological features from inferred
sparse co-expression networks—such as node degree—are predictive
of LOAD driver genes as identified in GWAS, and more so than dif-
ferential expression features. Finally, we show that our ranking
methodology identifies several previously known LOAD loci impli-
cated in other studies (Jonsson et al., 2013; Ki et al., 2002; Kiyota
et al., 2015; Mukherjee et al., 2017) as well potentially new LOAD
risk loci. These findings may lead to new mechanistic hypotheses
regarding the genetic drivers of LOAD. Furthermore, a Gene
Ontology (Chen et al., 2013) pathway analysis of the highly ranked
predicted driver genes identifies multiple pathways previously impli-
cated in LOAD disease etiology.
2 Materials and methods
2.1 Study description
In brief, all feature sets are derived from analyses of RNA-seq data
on 2114 samples from 1100 patients from seven distinct brain
regions (Temporal Cortex, Cerebellum, Frontal Pole, Inferior
Frontal Gyrus, Superior Temporal Gyrus, Parahippocampal Gyrus
and Dorsolateral prefrontal cortex) and three studies—the Mount
Sinai Brain Bank study (Wang et al., 2018), the Mayo RNA-seq
study (Allen et al., 2016) and the ROSMAP study (A Bennett et al.,
2012). A full description of the data and the RNA-seq processing
pipeline that was used to generate analytic outputs is described in
Logsdon et al. (2019).
2.2 Deriving usable features for meta-analysis
Features were inferred from specific statistical analyses that were
run on RNA-seq datasets within each of the seven tissue types.
These analyses included set membership features from differential
expression analysis (e.g. test of changes in mean expression between
AD cases/controls and subgroups such as males and females), global
network features from a sparse ensemble co-expression network in-
ference method described in further detail in Logsdon et al. (2019),
and network topological features for communities of genes identi-
fied from the networks described in the same paper. The sparse net-
work inference approach applies 17 distinct co-expression network
inference algorithms (including ARACNe, Genie3, Tigress,
Aparrow, Lasso, Ridge, c3net and WGCNA) to data derived from
each tissue type, and averages across the edge strength rankings
Table 1. Description of various feature sets used for multiview evidence aggregation
Feature set SynapseID No. features Type Descriptions
Differential expression syn18097426 250 Binary Membership based on differential expression in different brain
regions and patient subgroups (such as males/females)
Global network syn18097427 42 Numeric Features derived from graph structure in different brain regions
Module network syn18097424 66 Numeric Features derived from graph structure in important co-expression
modules from different brain regions
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from each method to determine an ensemble sparse representation
of co-expression relationships (see Logsdon et al., 2019) for details).
In all network type features we extract standard network topologic-
al characteristics such degree, authority score, betweeness centrail-
ity, pagerank and closeness.
2.3 Iterative multiview classification for driver
prediction
Here, we pose the driver gene prediction as a binary classification
problem using corrupted labels (Fre´nay and Verleysen, 2014).
Formally, given a feature vector Xi 2 Rd for a gene denoted by the
index i, we wish to predict a class label from {0, 1} where 1 would
indicate that the gene is a driver gene and 0 if it’s not. Additionally,
we also desire to predict the conditional probability for of a gene
being a driver, given the feature information, i.e. PðY^ i ¼ 1jX ¼ XiÞ.
This problem is solved by a broad class of binary classification prob-
lems such as logistic regression, support vector machines etc. in the
presence of a training dataset with input features and output class
labels. However, here we are only provided a list of a small subset of
drivers (from existing literature), whereas all other genes may or
may not be a driver. Mathematically, this is akin to learning from
noisy labels ~Y instead of the actual labels Y where PðY ¼ 1j ~Y ¼
1Þ ¼ 1 but PðY ¼ 0j ~Y ¼ 0Þ 6¼ 1. While there are many general strat-
egies for learning from noisy labels such as removing bad data
points, active learning etc. (Fre´nay and Verleysen, 2014), they gener-
ally don’t account for this specific type of label noise or make
assumptions about rates of mis-labeling in each class. Hence, here
we focus on a simple existing approach for such problems (Iterative
Classification) and propose a variant of it utilizing the fact that we
have features from multiple views for the same genes.
2.3.1 Iterative classifier
Iterative classification is a simple approach where the general idea is
to update the labels samples where ~Y 6¼ 1 to that of the predicted
class Y^ after each iteration of model training (Liu et al., 2003). This
can be written in algorithmic terms as in Algorithm 1. While this al-
gorithm is general and can be used for different classifiers, here we
demonstrate it on a L2-penalized logistic regression. Here, ll denotes
the maximum likelihood loss for logistic regression and thresh is a
constant in ½0;1, typically chosen to be greater than 0.5. The higher
the threshold, the more conservative the iterative updates are, acting
as a trade-off between specificity and sensitivity.
In the presence of data from multiple views from the same sam-
ples fXigKi¼1, the algorithm is run for each view separately and an
average of the predicted probabilities of all models is considered
while evaluating the final multiview predictions (we shall refer to
this as ’consensus’ for short in later text and figures).
2.3.2 Iterative classifier with co-training
While the previous algorithm solves the problem of noisy labels and
integrates information from multiple views, it does so by training
models for each individual view independently. However, as seen in
Figure 1, the features for different views are generated from the
same underlying source, i.e. the RNA-Seq data from brain samples
of patients and controls. Hence, the different views can be seen as
functional transformations of the same underlying data, corrupted
with different noise sources and should encode the same classifica-
tion information.
In the case of original multiview classification problems, it is
common to enforce view similarity which requires predictions
made by different views to be similar to each other, through co-
training or co-regularization (Xu et al., 2013). Here, the problem
is more difficult to the noise in the labels. Hence, we develop a
method which integrates the iterative updating scheme developed
Fig. 1. RNA-Seq data for AD patients and controls were derived for seven different brain regions from three centers. Differential expression, co-expression mod-
ule and global network features were derived from all brain regions. Each feature and known drivers were used to build predictive models for driver genes.
These driver probabilities and GWAS statistics were used for an evidence-based driver ranking
Algorithm 1. Iterative classification with L2-penalized logistic
regression
function IC(X; ~Y ;maxiters; thresh; k)
y ~Y
for iter 1 . . . maxiters do
w^ ¼ argminw1=N
PN
k¼1llðykjXk;wÞ þ kjjwjj22
for j 1 . . .N s.t. ~Y j 6¼ 1 do
pj  Pðyj ¼ 1jXj; w^Þ
yj  1ðPðyj ¼ 1jXj; w^Þ  threshÞ
end for
end for
return p, y
end function
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previously with co-training. Formally, we pose the problem of it-
eratively learning labels with co-training as the following opti-
mization problem:
argmin
fwkgKk¼1 ;fyki gKk¼1
 1
N
XK
k¼1
XN
i¼1
llðykjXki ;wkÞ þ kkjjwkjj22
" #
þq
4
XK
k¼1
XK
k0¼1
jjyk  yk0jj22
subject to:
yk 2 f0; 1gN ; yki ¼ 1; 8 ~Y i ¼ 1
It can be seen that this is a mixed-integer optimization problem,
which is a particularly hard class of optimization problems to solve.
However, for fixed fykgKk¼1, the optimization problem is convex in
fwkgKk¼1 and is simply logistic regression for the different views.
Hence, a locally optimal solution to the optimization problem is via
alternative minimization on fykgKk¼1 and fwkgKk¼1 starting with
f ~Y kgKk¼1. Unfortunately, the problem of optimizing over fykgKk¼1 is a
constrained binary quadratic programming problem, which does
not have exact solutions or efficient exact solvers (Kochenberger
et al., 2014). However, upon relaxing the binary constraint to a lin-
ear constraint (f0; 1g ! [0, 1]), the optimization problem becomes a
tractable convex optimization problem:
argmin
fykgKk¼1
 1
N
XK
k¼1
XN
i¼1
yki log
Pðyki ¼ 1jXkTi ;wkÞ
Pðyki ¼ 0jXkTi ;wkÞ
 !
þ
"
q
4
XK
k¼1
XK
k0¼1
jjyk  yk0jj22
#
subject to:
0  yk  1; yki ¼ 1 8 ~Y i ¼ 1
Here, we note that logðORki Þ ¼ log Pðy
k
i
¼1jXkTi ;wkÞ
Pðyk
i
¼0jXkT
i
;wkÞ
 
. We note that
this optimization problem is independent in each i and can be solved
independently. Next we demonstrate that the previously posed lin-
ear relaxation which can be solved using the co-ordinate descent
methodology using a closed form update rule for each yki .
Claim 1: A co-ordinate descent strategy leads to an optimal solution to
the previously stated optimization problem.
PROOF: It is sufficient to show that the optimization problem is convex.
Since the inequality constraints are linear in yki ’s, to demonstrate convex-
ity of the optimization problem, we simply need to demonstrate that the
cost function is convex. This can be shown by re-parameterizing the
problem for the ith variable in terms of a new variable xi ¼ ½y1i ; ::; yKi .
JðxiÞ ¼ q
4
XK
j¼1
XK
k¼1
jjAkj xijj22 þ bTxi
Where; ðAkj Þpq ¼
1; for p ¼ j;q ¼ k
1; for p ¼ k; q ¼ j
0; Otherwise
8<
:
And;bT ¼ 1
N
log10ðOR1i Þ; ::; log10ðORKi Þ
h i
Next, we calculate the second derivative of JðxiÞ:
r2JðxiÞ ¼ q
4
XK
j¼1
XK
k¼1
ðAkj ÞTAkj
We see that, since this is a sum of positive semi-definite matrices,
r2JðxiÞ0 for all xi, which is a sufficient condition for convexity
(Q.E.D.).
Claim 2: The previously stated optimization problem has a closed form
co-ordinate descent rule given by:
yki ¼ max 0;min
1
K 1
X
j6¼k
yji þ
1
Nq
logðORki Þ;1
( )( )
8i 2 f1; ::;Ng s:t: ~Y i 6¼ 1; 8k 2 f1; ::;Kg
PROOF: The loss function for each yki can be written as:
Jðyki Þ ¼ 
1
N
yki logðORki Þ þ
q
2
X
k0 6¼k
ðyki  yk
0
i Þ2 (1)
It is easy to see that this is a parabola of the form y ¼ aðx bÞ2 þ c. For
a parabola of this form, the minima (if a> 0) or maxima (if a< 0) occurs
at x¼ b. For our cost function, we see that a ¼ ðK1Þq2 > 0 and
b ¼ 1K1
P
j6¼k y
j
i þ 1Nq logðORki Þ. Hence,
dJðyk
i
Þ
dyk
i
< 0 if yki < b;
dJðyk
i
Þ
dyk
i
¼ 0 if
yki ¼ b and dJðy
k
i Þ
dyk
i
> 0 if yki > b. We now look at three possible locations
of yki ¼ b with respect to the interval yki 2 ½0; 1 and the constrained
minima in each case:
Case I (b 2 ½0; 1): Here, the constrained minima is the same as the global
minima.
Case II (b< 0): Here,
dJðyki Þ
dyk
i
> 0 in ½0; 1. Hence, the constrained minima
occurs at yki ¼ 0.
Case III (b> 0): Here,
dJðyk
i
Þ
dyk
i
< 0 in ½0; 1. Hence, the constrained minima
occurs at yki ¼ 1.
Algorithm 2. Iterative classifier with co-training
function ICCT(fXigKi¼1; ~Y ;maxiters; thresh; k;q)
yk  ~Y 8k 2 f1; ::;Kg
for iter 1 . . .maxiters do
for k 1 . . .K do
w^k ¼ argminwk 1=N
PN
l¼1llðyljXkl ;wkÞ þ kjjwkjj22
end for
for j 1 . . .N s.t. ~Y j 6¼ 1 do
for k 1 . . .K do
pkj  Pðyj ¼ 1jXk; w^kÞ
ykj  1ðyk;LRj  threshÞ
end for
end for
end for
return fpigKi¼1; fyigKi¼1
end function
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Now, compiling the closed form solutions in the three cases, we can
re-write the co-ordinate descent rule as yji ¼ max 0;min 1K1
P
j6¼k y
j
iþ
nn
1
Nq logðORki Þ; 1
oo
(Q.E.D.).
The solutions can then be binarized by selecting an appropriate
threshold like in the previous algorithm. An interesting observation
is that the update rule for any yk is simply an average of all the other
y’s and an additional term which is solely dependent on the
odds ratio of the kth view. This can be implemented as seen in
Algorithm 2.
Similar to the separately trained approach, consensus is taken to
obtain final multiview predictions.
2.3.3 Implementation and hyperparameter tuning
Both multiview iterative learning schemes were built using the
Logistic regression in the sci-kit learn package of Python. A general-
izable implementation of the code can be found at the link men-
tioned in the abstract. Values of k for each feature set were chosen
using a 10-fold cross-validation approach using the original labels
using the LogisticRegressionCV function in sci-kit learn. The value
of q was chosen to be 1=N for analysis of the RNA-Seq dataset
based on performance on the benchmark datasets.
2.4 Evidence aggregated ranking
The goal of the evidence aggregated ranking scheme is to aggregate
the predictions of the models trained using different feature sets and
also (optionally) integrate unrelated external information from large
sample GWAS studies. Here, we develop a flexible scoring system
that achieves the above stated goal:
ScoreðGeneiÞ ¼ a
K
XK
j¼1
log 10ðORjiÞ
 1 ajSNPðGeneiÞj
X
k2SNPðGeneiÞ
log 10ðpvalueÞk
Here, a 2 ð0; 1 is a user specified weighting parameter which
controls the relative importance given to the external GWAS evi-
dence vis-a-vis the model predictions using our feature sets, and
jSNPðGeneiÞj refers to the number of single nucleotide polymor-
phisms (SNPs) in a pre-specified window around Genei. The models
themselves are weighed equally relative to each other. For the pur-
poses of this paper we chose the a ¼ 0:5, thereby assigning equal
weight to our model predictions and external GWAS evidence. The
average of log transformed SNP P-value is chosen instead of the
minimum P-value (MP) in order to capture the composite effect of
all SNPs in a gene.
3 Results
3.1 Comparison of learning approaches on benchmark
datasets
To first test quantitatively test the relative efficiency of the two
learning approaches, we first test them on some standard bench-
mark datasets obtained from https://github.com/yeqinglee/mvdata
[used in Li et al. (2015)]:
Handwritten digits: This is a dataset containing handwritten dig-
its (0 through 9) originally from UCI’s Machine Learning repository.
It consists of 2000 data points. We use three of the published fea-
tures namely: 240 pixel averages in 23 windows, 76 Fourier coef-
ficients of the character shapes and 216 profile correlations.
Caltech-101: This is a dataset comprising of seven classes of
images amount to a total of 1474 images (Dueck and Frey, 2007).
We use three of the published features namely: 48 Gabor features,
254 CENTRIST features and 40 features derived from Wavelet
moments.
For each dataset, we performed binary classification with differ-
ent algorithms on each class separately, after corrupting the labels
by randomly deleting 50% of the ’true’ class labels to simulate the
driver identification problem. The training was performed on cor-
rupted labels while testing was performed on the actual labels.
Algorithms were compared by their mean accuracy across all the
class labels on the actual class labels. The algorithms compared
were: (i) Iterative classifiers (ICs) trained on each feature type separ-
ately, (ii) ICs trained on each feature type separately followed by
consensus among the learned models (using simple majority), (iii) IC
trained on a ‘stacked’ feature set (all feature sets were horizontally
stacked into one) and (iv) IC with co-training.
As seen in Figure 2, we see that IC with co-training outperforms
other algorithms on both standard datasets by a large margin, while
IC with consensus does not always lead to improvements over the
best single view iteratively trained model. The stacked model tends
to perform better than the best single view model but not as well as
iterative classifier with co-training (ICCT) in either dataset. This is
perhaps because the difference in information content between the
different views can sometimes make taking consensus ineffective.
3.2 Validation of driver prediction using independent
GWAS datasets
To validate our multiview data aggregation schemes and generate a
biologically meaningful ranking, we first generated gene-wise sum-
mary statistics from two separate GWAS datasets, namely IGAP
(Lambert et al., 2013) and Jansen (Jansen et al., 2019). The IGAP
study has a sample size of 74 046 (25 580 cases and 48 466 controls)
from individuals of European ancestry with over 7 million total
SNPs. The Jansen study has a sample size of 455 258 (71 880 cases,
383 378 controls) also from European ancestry. This study contains
in the addition to the data used in the IGAP study in addition to 3
complementary studies: Alzheimer’s Disease Sequencing Project
(ADSP), Psychiatric Genomics Consortium (PGC-ALZ) and UK
Biobank studies.
For each of these GWAS datasets, we generated two gene-wise
summary statistics, namely: (i) mean of log P-value of SNPs (MLP)
and (ii) MP of SNPs. This was done by mapping each SNPs to a
Fig. 2. Comparison of various classification algorithms trained on corrupted
class labels and tested on actual labels
i572 S.Mukherjee et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/bioinform
atics/article-abstract/35/14/i568/5529227 by Jackson Laboratory user on 16 Septem
ber 2019
10 kb window around known protein coding gene locations in a ref-
erence genome (hg38) and then computing the two summary statis-
tics of interest per gene. The mapping of SNPs to genes was
performed using the MAGMA software package (de Leeuw et al.,
2015).
Similar to the benchmark datasets, we trained both IC and ICCT
models on the three previously mentioned feature sets to obtain
probabilities of all genes being driver genes for AD. We first per-
formed a validation using a leave-one-out approach where we
trained models excluding one driver gene each time and compared
the predicted probability for the held out gene for ICCT and IC
approaches. We find a stark improvement in the performance at pre-
dicting the driver probability by ICCT (mean ¼ 0.47, median ¼
0.59, standard deviation ¼ 0.36) when compared with IC (mean ¼
0.24, median ¼ 0.09, standard deviation ¼ 0.29). In the absence of
true labels for validation, we adopt a qualitative metric to further
test the model accuracies using external GWAS data. This was done
by performing a Mann–Whitney U test between the distributions of
MP/MLP values of predicted driver genes and genes not predicted to
be drivers. A significant difference between the distributions would
suggest that predicted driver genes contain more genes significant to
AD than non-driver genes. Using this metric, we find that the ICCT-
consensus model shows the strongest difference between the
distributions (measured using the Mann–Whitney U test P-value),
followed by models trained on the network topological features
trained as a part of the ICCT algorithm (Fig. 3). It is seen in both
datasets, that even some feature set specific predictions of the ICCT
algorithm outperforms the basic iterative learning approach (IC),
demonstrating the utility of co-training. Interestingly, the high rela-
tive performance of the network topological features when com-
pared with the differential expression features implies that local and
global network structure plays a strong role in determining which
genes have causal effects on Alzheimers.
3.3 Biological analysis of predicted drivers
Having demonstrated the statistical significance of the predicted
driver genes, we ranked them using our ranking schema. The top 20
ranked genes can be seen in Table 2, which contains several genes
strongly linked with AD such as APOE, APOC1, CD74, TREM2,
SLC7A7 (Jonsson et al., 2013; Ki et al., 2002; Kiyota et al., 2015;
Mukherjee et al., 2017) etc. Table 2 also contains the minimum SNP
P-values for each of these genes according to the IGAP and Jansen
studies. It can be seen that while our models are not trained on any
SNP information, the results strongly align with additional valid-
ation GWAS data.
To further validate the results we performed gene set enrichment
analyses with the top-500 ranked potential driver genes using
Enrichr (Chen et al., 2013), a web based gene set enrichment tool.
The top 20 significant processes and functions ranked according to
their adjusted P-values can be seen in Table 3. Several of the proc-
esses such as immune response, amyloid processing, amyloid cata-
blism, amyloid clearance and apoptotic processes, and functions
such as low-density lipoprotein binding and activity are already
known to significantly altered in AD, whereas several other interest-
ing ones such as endocytosis, scavenger receptor activity and peptid-
ase activity can lead to potential new insights into AD disease
mechanisms.
3.4 Analysis of top features for driver prediction models
Having noted that the network topological features provide are
more predictive of the driver ranking of genes, we evaluate the most
Fig. 3. (A) Results of the Mann–Whitney U test performed on IGAP and
Jansen MP distributions for predicted driver versus non-driver genes. (B)
Results of the t-test performed on IGAP and Jansen MLP distributions for pre-
dicted driver versus non-driver genes
Table 2. Top 20 ranked genes along with their associated driver
score and minimum P-value from IGAP (Lambert et al., 2013) and
Jansen (Jansen et al., 2019) GWAS datasets
Genes Driver score Jansen P-value IGAP P-value
APOC1 42.92 <1E308 <1E308
APOE 41.75 <1E308 <1E308
BCAM 5.88 1.60E143 4.66E69
CD74 4.92 1.93E02 1.20E01
TREM2 4.65 2.95E15 1.07E03
CLPTM1 4.58 7.07E50 2.80E21
DEF6 4.28 5.94E03 3.52E02
SLC7A7 4.05 2.29E03 2.36E02
DOCK2 3.72 9.14E04 4.82E03
SPI1 3.62 1.06E06 1.99E06
STEAP3 3.61 3.63E05 2.21E02
PICALM 3.56 2.19E18 1.91E12
HMOX1 3.56 1.16E02 1.43E01
CLU 3.55 2.61E19 2.48E17
MS4A6A 3.55 1.55E15 6.64E11
IRF5 3.45 1.21E02 1.48E02
TYROBP 3.44 1.34E02 5.40E02
PARVG 3.42 1.44E02 1.05E03
ITGAL 3.41 1.92E04 4.36E03
PTPRC 3.33 2.12E03 7.24E03
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predictive features of each of the network feature sets in Table 4.
We calculated the Spearman’s rank correlation for each feature with
the model predictions for their feature set, to evaluate their relative
predictive power. Interestingly, we find several highly correlated fea-
tures from both feature sets. Upon closer look at the top 10 highly
correlated features from the Module-Network feature set all are
negatively correlated, with all the features derived from with
DLPFC (Dorsolateral Prefrontal Cortex) and TCX (Temporal
Cortex) brain regions. This is intriguing because the sample size in
DLPFC is largest (n¼630), and the signal to noise ratio in TCX is
highest (it is a highly affected brain region, and the median depth of
sequencing for that study was 60 million reads compared with
35 million for the other studies). The same trend cannot be observed
in the Global-Network feature set, where the top 10 features are
associated with STG (Superior Temporal Gyrus), PHG (Parahip
pocampal Gyrus) and DLPFC brain regions and all the correlations
are positive. However, in this case, the top features are all associated
with high connectivity of genes, which agrees with the popular
notion that driver genes are also typically hub genes (Liu et al.,
2012, 2011; Mukherjee et al., 2018). This can also be seen in
Figure 4, where we note that most of the known drivers lie in one of
the islands of genes (in the principle component plot) which corre-
sponds to genes with very high degrees (or hubs).
4 Conclusion
Here, we provide a generalizable framework for integration of di-
verse systems biology outputs to rank and identify new transcrip-
tomic and genetic drivers of Alzheimer’s disease. This provides
evidence that integration of multiple systems biology resources can
provide insights into new Alzheimer’s disease loci, which can help
researchers prioritize future experimental studies focusing on specif-
ic genes and pathways that are driving disease etiology. While not
all genes in genomic neighborhoods implicated by GWAS may actu-
ally be causal drivers of disease, we expect genes implicated in
GWAS to be highly enriched for disease specific drivers. Our ap-
proach takes these genes implicated from GWAS analyses and finds
common patterns from expression data that are predictive of these
genes. We do not expect the predictions from our model to be de-
void of false positives, but we do expect genes that are in fact genetic
drivers to be ranked higher by our model—which we see evidence of
when looking at the (Jansen et al., 2019) summary statistics.
We currently demonstrate the utility of the approach on three
RNA-Seq derived feature sets, providing strong qualitative agree-
ment with known biology as well as previously published GWAS
studies. Furthermore, we show the approach for driver gene predic-
tion itself is a broadly application machine learning approach by
demonstrating quantitative performance improvement over baseline
models.
Table 3. Top 20 enriched genesets for biological process and function along with their associated adjusted P-values obtained from Enrichr
(Chen et al., 2013)
GO biological process Adjusted P-value GO molecular function Adjusted P-value
Neutrophil mediated immunity 3.03E12 MHC Class II receptor activity 7.67E03
Neutrophil activation involved in immune response 3.03E12 Activin binding 7.67E03
Neutrophil degranulation 4.62E12 MHC Class II protein complex binding 7.67E03
Interferon-gamma-mediated signaling pathway 4.62E12 MHC protein complex binding 7.67E03
Cytokine-mediated signaling pathway 9.91E11 Transforming growth factor beta binding 7.67E03
Cellular response to interferon-gamma 5.79E10 Phosphotyrosine residue binding 7.67E03
Negative regulation of amyloid precursor protein
catabolic process
7.71E05 Transforming growth factor beta receptor binding 7.67E03
Regulation of amyloid-beta formation 7.94E05 Amyloid-beta binding 7.67E03
Positive regulation of intracellular signal
transduction
1.62E04 Scavenger receptor activity 1.04E02
Positive regulation of actin nucleation 1.68E04 Protein phosphorylated amino acid binding 1.09E02
Endocytosis 2.26E04 Low-density lipoprotein receptor activity 1.42E02
Regulation of mast cell degranulation 3.07E04 Phosphatidylinositol bisphosphate binding 1.42E02
Regulation of apoptotic process 3.07E04 Protein kinase binding 1.42E02
Extracellular matrix organization 3.07E04 Clathrin heavy chain binding 1.91E02
Negative regulation of amyloid-beta formation 4.01E04 Lipoprotein particle receptor activity 1.95E02
Antigen receptor-mediated signaling pathway 4.01E04 GTPase regulator activity 2.02E02
Negative regulation of extrinsic apoptotic signaling
pathway
5.26E04 Actin binding 2.23E02
Regulation of amyloid-beta clearance 5.77E04 Type II transforming growth factor beta receptor
binding
2.30E02
T cell receptor signaling pathway 5.77E04 Low-density lipoprotein particle binding 2.30E02
Cellular response to transforming growth factor
beta stimulus
1.09E03 Peptidase activity, acting on L-amino acid peptides 2.30E02
Table 4. Spearman rank correlation (with model predictions) for
the top 10 features of network topological feature sets
Module net qs Global net qs
TCXbrownTCXauthority 0.36 STGcloseness 0.58
TCXbrownTCXdegree 0.36 STGdegree 0.57
TCXbrownTCXeccentricity 0.36 STGauthority 0.57
DLPFCredDLPFCauthority 0.34 PHGauthority 0.54
DLPFCredDLPFCeccentricity 0.34 STGpagerank 0.53
TCXbrownTCXcloseness 0.34 PHGdegree 0.53
DLPFCredDLPFCdegree 0.34 PHGcloseness 0.52
TCXbrownTCXpagerank 0.34 DLPFCauthority 0.52
DLPFCredDLPFCcloseness 0.33 STGcentr_betw 0.50
DLPFCredDLPFCpagerank 0.33 DLPFCdegree 0.50
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While the current work has focused on engineering and using
RNA-Seq feature sets, future work will focus on integrating other -
omics datasets from the AMP-AD study to further improve the evi-
dence driven ranking of driver genes. Another direction of future
work will focus on identifying the relevance and agreement of differ-
ent feature views. While the current approach equally weighs the
predictions from different feature views, this may be unadvisable if a
feature view has limited information about the driverness of genes.
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